World Journal of Urology 2012-05-01

Trospium chloride--an effective drug in the treatment of overactive bladder and detrusor hyperreflexia.

Raktim Kumar Ghosh, Samhati Mondal Ghosh

Index: World J. Urol. 19(5) , 336-43, (2001)

Full Text: HTML

Abstract

Trospium chloride (TCL), a quaternary ammonium derivative of nortropanol, has been evaluated in a number of clinical and pharmacological studies. Selected pharmacological and clinical pharmacokinetic data are discussed as providing a basis for a better interpretation and understanding of the clinical trial results. An overview of the results of 20 clinical trials and post-marketing surveillance studies including more than 10000 patients is presented.

Related Compounds

  • Trospium Chloride

Related Articles:

New strategies for medical management of overactive bladder in children.

2010-07-01

[Curr. Opin. Urol. 20(4) , 313-7, (2010)]

What is the success of drug treatment in urge urinary incontinence? What should be measured?

2013-03-01

[Arch. Gynecol. Obstet. 287(3) , 511-8, (2013)]

Benefits and harms of pharmacologic treatment for urinary incontinence in women: a systematic review.

2012-06-19

[Ann. Intern. Med. 156(12) , 861-74, W301-10, (2012)]

Mechanistic investigation of food effect on disintegration and dissolution of BCS class III compound solid formulations: the importance of viscosity.

2012-10-01

[Biopharm. Drug Dispos. 33(7) , 403-16, (2012)]

Mechanistic basis for unexpected bioavailability enhancement of polyelectrolyte complexes incorporating BCS class III drugs and carrageenans.

2013-09-01

[Eur. J. Pharm. Biopharm. 85(1) , 26-33, (2013)]

More Articles...